A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study to Evaluate the Dose-Response Relationship of the Efficacy and Safety of Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period
Phase of Trial: Phase II/III
Latest Information Update: 18 Aug 2018
At a glance
- Drugs Celecoxib (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 23 Jul 2018 Status changed from active, no longer recruiting to completed.
- 31 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Apr 2017 New trial record